BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36877279)

  • 1. TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.
    Strassl I; Windhager A; Machherndl-Spandl S; Buxhofer-Ausch V; Stiefel O; Weltermann A
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7113-7123. PubMed ID: 36877279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
    Whitman AM; DeGregory KA; Morris AL; Ramsdale EE
    Oncologist; 2016 Jun; 21(6):723-30. PubMed ID: 27151653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.
    Sallevelt BTGM; Huibers CJA; Heij JMJO; Egberts TCG; van Puijenbroek EP; Shen Z; Spruit MR; Jungo KT; Rodondi N; Dalleur O; Spinewine A; Jennings E; O'Mahony D; Wilting I; Knol W
    Drugs Aging; 2022 Jan; 39(1):59-73. PubMed ID: 34877629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting.
    Huibers CJA; Sallevelt BTGM; Heij JMJO; O'Mahony D; Rodondi N; Dalleur O; van Marum RJ; Egberts ACG; Wilting I; Knol W
    Eur Geriatr Med; 2022 Jun; 13(3):541-552. PubMed ID: 35291025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedside medication review with cognitive and depression screening by a clinical pharmacist as part of a comprehensive geriatric assessment in hospitalized older patients with polypharmacy: A pilot study.
    Mertens V; Jacobs L; Knops N; Alemzadeh SM; Vandeven K; Swartenbroekx J; Moorkens G; Vandewoude M
    PLoS One; 2022; 17(10):e0276402. PubMed ID: 36269748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared Decision-Making in Chronic Patients with Polypharmacy: An Interventional Study for Assessing Medication Appropriateness.
    Coronado-Vázquez V; Gómez-Salgado J; Cerezo-Espinosa de Los Monteros J; Ayuso-Murillo D; Ruiz-Frutos C
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31238559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer.
    Mohamed MR; Mohile SG; Juba KM; Awad H; Wells M; Loh KP; Flannery M; Culakova E; Tylock RG; Ramsdale EE
    Cancer; 2023 Apr; 129(7):1096-1104. PubMed ID: 36692475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system.
    Crowley EK; Sallevelt BTGM; Huibers CJA; Murphy KD; Spruit M; Shen Z; Boland B; Spinewine A; Dalleur O; Moutzouri E; Löwe A; Feller M; Schwab N; Adam L; Wilting I; Knol W; Rodondi N; Byrne S; O'Mahony D
    BMC Health Serv Res; 2020 Mar; 20(1):220. PubMed ID: 32183810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment.
    Ramsdale E; Mohamed M; Yu V; Otto E; Juba K; Awad H; Moorthi K; Plumb S; Patil A; Vogelzang N; Dib E; Mohile S
    Oncologist; 2022 Jul; 27(7):e580-e588. PubMed ID: 35348764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial.
    Jungo KT; Rozsnyai Z; Mantelli S; Floriani C; Löwe AL; Lindemann F; Schwab N; Meier R; Elloumi L; Huibers CJA; Sallevelt BTGM; Meulendijk MC; Reeve E; Feller M; Schneider C; Bhend H; Bürki PM; Trelle S; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMJ Open; 2019 Sep; 9(9):e031080. PubMed ID: 31481568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia.
    Adem L; Tegegne GT
    Clin Interv Aging; 2022; 17():509-517. PubMed ID: 35464156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Medication Use of Cancer and Non-Cancer Patients in Home Hospice Care in Singapore: A Retrospective Study from 2011 to 2015.
    Wenedy A; Lim YQ; Lin Ronggui CK; Koh GCH; Chong PH; Chew LST
    J Palliat Med; 2019 Oct; 22(10):1243-1251. PubMed ID: 31066621
    [No Abstract]   [Full Text] [Related]  

  • 15. Using an Electronic Decision Support Tool to Reduce Inappropriate Polypharmacy and Optimize Medicines: Rationale and Methods.
    Young A; Tordoff J; Dovey S; Reith D; Lloyd H; Tilyard M; Smith A
    JMIR Res Protoc; 2016 Jun; 5(2):e105. PubMed ID: 27288200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
    Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
    Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes.
    García-Caballero TM; Lojo J; Menéndez C; Fernández-Álvarez R; Mateos R; Garcia-Caballero A
    Int Psychogeriatr; 2018 Jul; 30(7):1001-1008. PubMed ID: 29747709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to reduce polypharmacy and optimize medication use in older adults with cancer.
    Barlow A; Prusak ES; Barlow B; Nightingale G
    J Geriatr Oncol; 2021 Jul; 12(6):863-871. PubMed ID: 33353854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
    Ross SB; Wilson MG; Papillon-Ferland L; Elsayed S; Wu PE; Battu K; Porter S; Rashidi B; Tamblyn R; Pilote L; Downar J; Bonnici A; Huang A; Lee TC; McDonald EG
    J Am Geriatr Soc; 2020 Aug; 68(8):1636-1646. PubMed ID: 32441771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study.
    Gutiérrez-Valencia M; Izquierdo M; Malafarina V; Alonso-Renedo J; González-Glaría B; Larrayoz-Sola B; Monforte-Gasque MP; Latasa-Zamalloa P; Martínez-Velilla N
    Geriatr Gerontol Int; 2017 Dec; 17(12):2354-2360. PubMed ID: 28422415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.